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Unexplained dizzinessIntroduction: Although cerebral small vessel disease is a signiﬁcant contributor to the development of imbalance
and falls in the elderly, whether it causes dizziness is not known.
Methods: A retrospective case analysis was conducted for 122 dizzy patients referred to two neuro-otology
tertiary centres in London and Pisa. Patients were divided into ‘explained’ causes of dizziness (e.g. benign
positional vertigo, vestibular neuritis, orthostatic hypotension, cerebellar ataxias) and ‘unexplained’ dizziness.
White matter hyperintensities (WMH) in MRI (T2 weighted and FLAIR sequences) were blindly rated according
to the Fazekas scale.
Results: 122 patients; 58 (mean age=72, SD=7.95 years) in the ‘unexplained’ group and 64 (mean age=72.01,
SD = 8.28 years) in the ‘explained’ group were recruited. The overall frequency of lesions (Fazekas 1–3)
signiﬁcantly differed between groups (p= 0.011). The frequency of severe lesions (Fazekas 3) was signiﬁcantly
higher in the ‘unexplained’ group (22%) than in the ‘explained’ group (5%; p = 0.003).
Conclusion: Increased severity of WMH in cases of unexplained dizziness suggests that such abnormalities are
likely contributory to the development of dizziness. WM lesions may induce dizziness either because patients
perceive a degree of objective unsteadiness or by a disconnection syndrome involving vestibular or locomotor
areas of the brain.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Cerebral white matter disease (WMD) and its role in cognitive
decline, falls and stroke [1,2], has generated immense interest over the
years. Although it is known that WMD is associated with gait and
posture abnormalities, a link between white matter abnormalities and
dizziness has not been established yet.
The diagnosis in older dizzy patients is challenging as there are often
multifactorial causes [3] and a large proportion of patients remain
undiagnosed. Patients often report non-speciﬁc dizziness, vague
unsteadiness, disequilibrium or even light headedness. With WMD
currently impacting 80% of the elderly population [4] and dizziness
affecting approximately 30% of the population over 65 years of age [5],
the signiﬁcance of research in this area cannot be underestimated. A
previous study by Day et al. [6] at the advent of routine MRI, recruitedeuro-otology, Division of Brain




. This is an open access article underdizzy patients but did not ﬁnd an appreciable difference between imag-
ing of dizzy and non-dizzy patients. However, the numbers were small
and the technique was new. Inﬂuential studies by Colledge et al. [7,8]
concluded there were no differences in imaging between dizzy and
non-dizzy subjects although increasedmidbrainwhitematter (WM) le-
sionswere noted. A very recent study in this journal, however, indicates
that the presence ofWM lesions is an independent predictor of residual
dizziness in patients with previous vestibular neuritis [9]. In order to re-
assess whether WMDmay directly contribute to dizziness, a retrospec-
tive cohort study was conducted.
2. Methods
Patients were included if they were aged between 45 and 90 years
and were referred with dizziness to tertiary referral neuro-otology
centres in London and Pisa. These are national centres of expertise in
the diagnosis, investigation and management of dizziness and imbal-
ance and are typically referred a combination of general and complex
dizzy patients. “Dizzy” symptoms included true rotational vertigo,
light-headedness, giddiness and a sense of non-speciﬁc unsteadiness.
Patients with no dizziness, psychogenic or functional dizziness, no
imaging available or CT scan only (n = 3) and age N 90 were excludedthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Patients were referred from general practitioners, neurologists and ear
nose and throat specialists from December 2010–2014. All patients
(81 in London and 41 in Pisa) had been seen and examined by experi-
enced neuro-otologists. For this study, the case notes were reviewed
and patients were divided into two groups based on history, clinical ex-
amination ﬁndings and laboratory results. Group 1 consisted of patients
with ‘explained’ causes of dizziness. These included benign positional
paroxysmal vertigo (BPPV — history of brief, positional, rotational
vertigo with positive Dix–Hallpike manoeuvre), vestibular neuritis
(history of acute prolonged rotational vertigo, associated with nausea,
vomiting and imbalance with spontaneous, horizontal, unidirectional,
nystagmus, with torsional component, unilaterally positive head
impulse test and no other neurological abnormality. Tests show unilat-
eral reduction of nystagmic response on calorics i.e. N25% canal paresis
and normal audiometry). Also included were vestibular migraine (his-
tory of at least ﬁve episodes of vestibular symptoms (vertigo/head mo-
tion induced dizziness) with temporally associated migrainous
headaches lasting from minutes up to 72 h), Meniere's disease (combi-
nation of vertigo, cochlear symptoms and low frequency sensorineural
hearing loss), bilateral vestibular loss (bilateral absence of nystagmic re-
sponse; b10 °/s slow phase velocity on calorics/rotational chair testing)
orthostatic hypotension (decrease in systolic blood pressure of
20mmHgor diastolic 10mmHg from lying to immediately on standing
and after 3 min) stroke, cerebellar ataxias, Parkinson's disease,
hydrocephalus and temporal bone fracture. Group 2 included patients
with ‘unexplained’ dizziness, i.e. no recognised diagnosis which could
account for the dizziness. For all patients both main and secondary
diagnoses are listed in Table 1.
Type of dizziness and vascular risk factors (heart disease, hyperten-
sion, diabetes, hypercholesterolemia, obesity, smoking and previous
stroke) were also noted.
Full neuro-otological examination included eye movements (spon-
taneous, gaze evoked and positional nystagmus, pursuit, saccades,
Dolls head, head-impulse test), cerebellar and sensory examination.
Speciﬁc attention was paid to the examination of gait and posture.Table 1
Demographics and diagnoses of unexplained and explained dizziness groups. Values















Male 28 (48) 31 (48)
Female 30 (52) 33 (51)
Diagnosisa
BPPV – 20 (31)
Vestibular neuritis – 17 (26)
Vestibular migraine – 10 (15)
Orthostatic hypotension – 6 (9)
Cerebellar ataxia – 6 (9)
Meniere’s disease – 5 (7)
Bilateral vestibular failure – 4 (6)






Migraine 7 (11) 2 (3)
BPPV 5 (8) 5 (7)
Orthostatic hypotension 2 (3) 2 (3)
a More diagnoses than patients are listed in the explained group due to a proportion of
patients with multiple diagnoses.Abnormalities of gait (eg. broad based/ataxic/apraxic) were recorded.
Tandem gait was considered abnormal if patients were unable to
perform the ‘heel to toe’ walk or if consistent stepping errors were
present. Romberg's test was classiﬁed as negative, excessive sway or
fall. Postural responses to push/pull of the upper trunk were rated as
abnormal if subjects would fall if not supported or exhibited
retropulsion/propulsion if corrective steps were absent or multiple
steps were needed to maintain posture. All patients underwent labora-
tory tests including audiometry, bithermal calorics or rotation chair
electronystagmography. All patients were also speciﬁcally asked about
postural symptoms (dizziness caused by upright posture relieved by
sitting or lying position). If present, postural blood pressure (supine,
immediately on standing and after 3min)wasmeasured. Brain imaging
(3 Tesla MRI) was reviewed by a neurologist blinded to the clinical de-
tails. White matter hyperintensities (WMH) on 122 MRI T2-weighted
and ﬂuid-attenuated inversion-recovery (FLAIR) sequences were rated
according to the Fazekas scale [10]. This is a scale gradingWMH burden
according to severity (0: none or a single punctate lesion; 1: multiple
punctate lesions; 2: early conﬂuency of lesions; 3: large conﬂuent
lesions). (Of note, in all cases, the blind assessment was found to be in
agreement with the independent neuro-radiologist report rating the
white matter lesion load as mild, moderate or severe).
Primary outcome was the degree of WMH in the two groups. A
Pearson's 2 × 3 chi-squared test was performed to analyse the differ-
ence in Fazekas scales between the groups. As a secondary analysis,
the presence or absence of rotational vertigo and gait and posture
abnormalities were analysed using a 2 × 2 chi-squared test. The degree
of total (aggregate) vascular risk factors between groups was compared
with a chi-squared test. Binary logistic regression was used to evaluate
the signiﬁcant predictors of unexplained dizziness. Statistical analysis
was performed using SPSS 22 (SPSS, Inc.; Chicago, USA) with signiﬁ-
cance set at p b 0.05.
3. Results
There were 64 patients (mean age 72.01 years, SD = 8.28), in the
“explained” group and 58 patients (mean 72 years, SD = 7.95) in the
“unexplained” group. Fig. 1 summarises the Fazekas scores in the two
groups. A signiﬁcant difference was observed between the overall
Fazekas scores in explained and unexplained dizzy groups (χ2 = 8.87,
df = 2, p= 0.011). The frequency of severe lesions (Fazekas 3)was sig-
niﬁcantly greater in the unexplained group (22%) than in the explained
group (5%); (χ28.39, df = 1, p = 0.003).
Gait and posture abnormalities, (errors in tandem walk, gait
dyspraxia, abnormal postural responses), were more frequent in the
unexplained group (45%) as compared to the explained group (25%),
(χ2 = 5.30, df = 1, p = 0.021). The presence of true rotational vertigo
was signiﬁcantly more frequent in the explained than in the unexplained
group (χ2 = 9.60, df = 1, p = 0.003).
The total (aggregate) vascular risk factors were 65% in the
unexplained group and 34% in the explained group (χ2 = 7.57, df = 1,
p= 0.005). However, Fazekas score was found to be the only signiﬁcant
predictor of unexplained dizziness (binary logistic regression; p =
0.023). In particular, vascular risk factors were not found to be
signiﬁcant predictors of unexplained dizziness (p N 0.05).
4. Discussion
To our knowledge this is the ﬁrst study to evaluate patients in
specialist clinics to assesswhetherWMH is associatedwith unexplained
dizziness. The relationship observed between increased severity
(Fazekas 3) of WMH in our “unexplained” group suggests these abnor-
malities are likely contributory to the development of the dizziness.
This is supported by the recent ﬁnding of WMH being a predictor of
chronic dizziness in patients with previous vestibular neuritis [9].
Fig. 1. Severity of white matter disease on MRI (Fazekas scores), expressed as percentage of patients with “explained” and “unexplained” causes of dizziness.
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were contributory to the unexplained dizziness. It should be noted
though that our two groups were age-matched hence increased
vascular risk factors cannot be solely attributed to age related changes.
Also, despite increased frequency of ‘central’ pathology (eg. ataxias) ob-
served in the ‘explained’ group the vascular risk factors were lower than
in the unexplained group. Furthermore, our regression analysis indi-
cates that the only predictor of unexplained dizziness was Fazekas
score but not vascular risk factors. In support of this, a recent prospec-
tive cohort study [11] of community dwellers found that vascular risk
factors combined could only explain 2% of variance inWMH suggesting
a non-vascular aetiology for development ofWMH,more so than previ-
ously considered.
It was also observed that the frequency of “true” rotational vertigo
was signiﬁcantly lower in the unexplained dizziness group with
respect to the explained group, as expected from the frequent peripheral
vestibular diagnoses in the latter group. However, recent studies
suggest that the type (quality) of dizziness may contribute little to
diagnosis [12,13]. These features, however, will have to be conﬁrmed
in future prospective studies. It is important to highlight that we do
not advocate the diagnosis of dizziness likely due to WMD on the
basis of imaging ﬁndings alone, given that the presence of common
and treatable causes of dizziness in this age group is high. In our sample,
26% of patients in the ‘explained’ group had moderate–severe (Fazekas
2–3) WMH and yet the main cause of the dizziness was BPPV, easily
treated with a simple and inexpensive re-positioning procedure such
as Epley or Semont manoeuvres.
We understand the limitations of this retrospective analysis, one of
which is the accuracy of original recorded data. Patients, however,
were seen by experienced neuro-otologistswhoperformed a structured
assessment minimising variability in record keeping. We also recognise
that future studies are necessary for a normal control group to be pro-
spectively assessed but in our study the explained dizzy group acted as
a valid retrospective control group. Furthermore, quantifying WMH
would be amore objectivewayof evaluating lesion burden and, perhaps
more importantly, localization. Whilst this may form the basis of future
work in this area, the Fazekas scale remains a validated tool in grading
WM lesions [14,15].
A previous, well conducted, prospective study [8] showed no major
MRI differences between dizzy and non-dizzy subjects. It is, however,
important to consider that ﬁrstly their subjects were recruited from
the community and were not necessarily patients. Secondly, the imag-
ing techniques were older, from the early 90's, and the association ofWMH with objective balance dysfunction was not established then as
it is now [16]. Our patients were recruited from tertiary neuro-otology
clinics and are likely to have more relevant symptoms of dizziness
hence explaining why structural abnormalities may not have been as
prevalent in their study. The intensity of the dizziness, however, was
not quantiﬁed with questionnaires in ours or previous studies and,
again, this will have to be undertaken in future prospective studies.5. Conclusion
We report that the severity of white matter small vessel disease is
higher in elderly patients with no speciﬁc cause for their dizziness
(“unexplained” dizziness). We postulate that white matter lesions
may induce dizziness either because patients perceive a degree of
objective unsteadiness or by a cortical–subcortical disconnection
syndrome, secondary to disruption of white matter tracts involved in
gait and balance control [16,17]. Contrary to previous studies, our
ﬁndings suggest that elderly patients with dizziness, without a clear
diagnosis and despite clinical and vestibular assessment, should
undergo brain imaging to assess the level of WMD. Currently
treatment involves preventive measures including control of vascular
co-morbidities [18]. Customised retraining through a combination of
rehabilitation and possibly neuro-modulation of cortical pathways
may form part of future potential treatment options for this subgroup
of dizzy patients [19].Contributions
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